sanofi-aventis Canada Inc.
Registration:
15
of
19
(2021-08-23
to
2022-01-03)
Details Regarding the Identified Subject Matter
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Negotiate funding parameters for Admelog - a biosimilar insulin
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|
Negotiate the listing of Dupixent on the BC PharmaCare formulary
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|
Participate in the MS Class Review project undertaken by the Pharmaceutical Services Division of the Ministry of Health
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|